Trial intelligence / Profile preview

Hemp Cream for Uremic Pruritus in Hemodialysis Patients

NCT06159686Phase 2Completed

Sponsor
Thammasat University Hospital
Start
Sep 2023
Primary completion
Dec 2023
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in uremic pruritus (2 arms), sponsored by Thammasat University Hospital. Primary endpoint: Worst Itching Numerical Rating Scale at 4 weeks. Started Sep 2023; status: completed.

02

Conditions

uremic pruritus

Beyond the preview

Go deeper on NCT06159686.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06159686.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call